Prevenar Antibody Response Into Adulthood Needs Study - FDA Cmte.

Postmarketing studies of Wyeth-Lederle's 7-valent (4, 6B, 9V, 14, 18c, 19F, 23F) pneumococcal conjugate vaccine Prevenar should evaluate duration of antibody response into adulthood, FDA's Vaccines & Related Biological Products Advisory Committee suggested Nov. 5.